Literature DB >> 9445011

Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L.

R K Maitra1, R H Silverman.   

Abstract

Activation of RNase L by 2',5'-linked oligoadenylates (2-5A) is one of the antiviral pathways of interferon action. To determine the involvement of the 2-5A system in the control of human immunodeficiency virus type 1 (HIV-1) replication, a segment of the HIV-1 nef gene was replaced with human RNase L cDNA. HIV-1 provirus containing sense orientation RNase L cDNA caused increased expression of RNase L and 500- to 1,000-fold inhibition of virus replication in Jurkat cells for a period of about 2 weeks. Subsequently, a partial deletion of the RNase L cDNA which coincided with increases in virus production occurred. The anti-HIV activity of RNase L correlated with decreases in HIV-1 RNA and with an acceleration in cell death accompanied by DNA fragmentation. Replication of HIV-1 encoding RNase L was also transiently suppressed in peripheral blood lymphocytes (PBL). In contrast, recombinant HIV containing reverse orientation RNase L cDNA caused decreased levels of RNase L, increases in HIV yields, and reductions in the anti-HIV effect of alpha interferon in PBL and in Jurkat cells. To obtain constitutive and continuous expression of RNase L cDNA, Jurkat cells were cotransfected with HIV-1 proviral DNA and with plasmid containing a cytomegalovirus promoter driving expression of RNase L cDNA. The RNase L plasmid suppressed HIV-1 replication by eightfold, while an antisense RNase L construct enhanced virus production by twofold. These findings demonstrate that RNase L can severely impair HIV replication and suggest involvement of the 2-5A system in the anti-HIV effect of alpha interferon.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445011      PMCID: PMC124589     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  RNase inhibition of human immunodeficiency virus infection of H9 cells.

Authors:  R J Youle; Y N Wu; S M Mikulski; K Shogen; R S Hamilton; D Newton; G D'Alessio; M Gravell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

2.  Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells.

Authors:  A G Laurent-Crawford; B Krust; Y Rivière; C Desgranges; S Muller; M P Kieny; C Dauguet; A G Hovanessian
Journal:  AIDS Res Hum Retroviruses       Date:  1993-08       Impact factor: 2.205

3.  Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action.

Authors:  A Zhou; B A Hassel; R H Silverman
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

4.  HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates.

Authors:  R W Sobol; W L Fisher; N L Reichenbach; A Kumar; W A Beard; S H Wilson; R Charubala; W Pfleiderer; R J Suhadolnik
Journal:  Biochemistry       Date:  1993-11-16       Impact factor: 3.162

5.  Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; A Schuster; M Bayer; J Pavlovic; V ter Meulen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Modulation of nuclear matrix-associated 2',5'-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus.

Authors:  H C Schröder; R Wenger; Y Kuchino; W E Müller
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

7.  Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta.

Authors:  V Vieillard; E Lauret; V Rousseau; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.

Authors:  P F Torrence; R K Maitra; K Lesiak; S Khamnei; A Zhou; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

9.  HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes.

Authors:  R K Maitra; N A McMillan; S Desai; J McSwiggen; A G Hovanessian; G Sen; B R Williams; R H Silverman
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

10.  Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment.

Authors:  E M Coccia; B Krust; A G Hovanessian
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

View more
  25 in total

Review 1.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

2.  The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells.

Authors:  H Elbahesh; B K Jha; R H Silverman; S V Scherbik; M A Brinton
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

3.  The IFITM proteins inhibit HIV-1 infection.

Authors:  Jennifer Lu; Qinghua Pan; Liwei Rong; Wei He; Shan-Lu Liu; Chen Liang
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

Review 4.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

Review 5.  Diverse functions of RNase L and implications in pathology.

Authors:  Catherine Bisbal; Robert H Silverman
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

6.  Involvement of the interferon-regulated antiviral proteins PKR and RNase L in reovirus-induced shutoff of cellular translation.

Authors:  Jennifer A Smith; Stephen C Schmechel; Bryan R G Williams; Robert H Silverman; Leslie A Schiff
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.

Authors:  Luca G Guidotti; Amber Morris; Heike Mendez; Rick Koch; Robert H Silverman; Bryan R G Williams; Francis V Chisari
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.

Authors:  C Martinand; C Montavon; T Salehzada; M Silhol; B Lebleu; C Bisbal
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons.

Authors:  M Scott Killian; Fernando Teque; Robert L Walker; Paul S Meltzer; J Keith Killian
Journal:  J Interferon Cytokine Res       Date:  2013-02-12       Impact factor: 2.607

10.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.